Number of the records: 1
famotidín
SYS d015738 LBL 00000nz--a2200000o--4500 005 20250606214050.9 008 920515|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D02.886.675.215 065 $a D03.383.129.708.215 066 $a 01 $c 03 150 $a famotidín $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 550 $7 sllk_us_auth*d000897 $Y Anti-Ulcer Agents $w P $a antiulceróza 550 $7 sllk_us_auth*d006635 $Y Histamine H2 Antagonists $w P $a antihistaminiká H2 665 $a 90 $2 eng 665 $a Anti-Ulcer Agents (1977-1989) $2 eng 665 $a Histamine H2 Receptor Blockaders (1977-1989) $2 eng 665 $a Thiazoles (1966-1989) $2 eng 680 9-
$i A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion. $2 eng 750 -2
$a Famotidine $2 eng 980 $x M
Number of the records: 1